NCT05796037
An Observational Study of Patients Living With Chronic Neurological Diseases
Not Yet Recruiting · Not specified · Target PharmaSolutions, Inc. · registry updated 2024-11-20
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
TARGET-NEURO is an observational research study to conduct a comprehensive review of outcomes for patients living with chronic neurological diseases: Alzheimer's disease and related dementia (ADRD), mild cognitive impairment (MCI), Parkinson's disease (PD), and multiple sclerosis (MS).
Inclusion
- Adult patients at the time of enrollment with a diagnosis of ADRD, MCI, PD, or MS by select ICD-10 codes in the EHR interface
Exclusion
- Manual removal (sponsor or site request)
- No EHR interface encounter \> 3 years
- Engaged Cohort
- Adult patients diagnosed and managed for these conditions invited to participate
- Ability to provide written informed consent (or have a legally authorized representative to provide informed consent)
- Care partners may be invited to participate in surveys and will provide informed consent.